77 related articles for article (PubMed ID: 10878006)
1. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
Ono T; Kitaura H; Ugai H; Murata T; Yokoyama KK; Iguchi-Ariga SM; Ariga H
J Biol Chem; 2000 Oct; 275(40):31145-54. PubMed ID: 10878006
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2.
Yam CH; Ng RW; Siu WY; Lau AW; Poon RY
Mol Cell Biol; 1999 Jan; 19(1):635-45. PubMed ID: 9858587
[TBL] [Abstract][Full Text] [Related]
3. The cyclin E/Cdk2 substrate and Cajal body component p220(NPAT) activates histone transcription through a novel LisH-like domain.
Wei Y; Jin J; Harper JW
Mol Cell Biol; 2003 May; 23(10):3669-80. PubMed ID: 12724424
[TBL] [Abstract][Full Text] [Related]
4. Complete inhibition of Cdk/cyclin by one molecule of p21(Cip1).
Hengst L; Göpfert U; Lashuel HA; Reed SI
Genes Dev; 1998 Dec; 12(24):3882-8. PubMed ID: 9869641
[TBL] [Abstract][Full Text] [Related]
5. Coupling of DNA synthesis and histone synthesis in S phase independent of cyclin/cdk2 activity.
Nelson DM; Ye X; Hall C; Santos H; Ma T; Kao GD; Yen TJ; Harper JW; Adams PD
Mol Cell Biol; 2002 Nov; 22(21):7459-72. PubMed ID: 12370293
[TBL] [Abstract][Full Text] [Related]
6. Involvement of cyclins in cell proliferation and their clinical implications in soft tissue smooth muscle tumors.
Noguchi T; Dobashi Y; Minehara H; Itoman M; Kameya T
Am J Pathol; 2000 Jun; 156(6):2135-47. PubMed ID: 10854234
[TBL] [Abstract][Full Text] [Related]
7. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells.
Rössig L; Jadidi AS; Urbich C; Badorff C; Zeiher AM; Dimmeler S
Mol Cell Biol; 2001 Aug; 21(16):5644-57. PubMed ID: 11463845
[TBL] [Abstract][Full Text] [Related]
8. Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.
Gong W; Russell M; Suzuki K; Riabowol K
Mol Cell Biol; 2006 Apr; 26(8):2947-54. PubMed ID: 16581770
[TBL] [Abstract][Full Text] [Related]
9. A premature-termination mutation in the Mus musculus cyclin-dependent kinase 3 gene.
Ye X; Zhu C; Harper JW
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1682-6. PubMed ID: 11172011
[TBL] [Abstract][Full Text] [Related]
10. The osmoregulatory and the amino acid-regulated responses of system A are mediated by different signal transduction pathways.
López-Fontanals M; Rodríguez-Mulero S; Casado FJ; Dérijard B; Pastor-Anglada M
J Gen Physiol; 2003 Jul; 122(1):5-16. PubMed ID: 12810851
[TBL] [Abstract][Full Text] [Related]
11. PAK4 kinase is essential for embryonic viability and for proper neuronal development.
Qu J; Li X; Novitch BG; Zheng Y; Kohn M; Xie JM; Kozinn S; Bronson R; Beg AA; Minden A
Mol Cell Biol; 2003 Oct; 23(20):7122-33. PubMed ID: 14517283
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.
Liu J; Yuan Y; Huan J; Shen Z
Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963
[TBL] [Abstract][Full Text] [Related]
13. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
[TBL] [Abstract][Full Text] [Related]
14. BCCIP suppresses tumor initiation but is required for tumor progression.
Huang YY; Dai L; Gaines D; Droz-Rosario R; Lu H; Liu J; Shen Z
Cancer Res; 2013 Dec; 73(23):7122-33. PubMed ID: 24145349
[TBL] [Abstract][Full Text] [Related]
15. Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues.
Liu X; Cao L; Ni J; Liu N; Zhao X; Wang Y; Zhu L; Wang L; Wang J; Yue Y; Cai Y; Jin J
Int J Oncol; 2013 Dec; 43(6):1925-34. PubMed ID: 24101097
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the BCCIP gene for breast cancer susceptibility in breast/ovarian cancer families.
Bonache S; Gutierrez-Enriquez S; Tenés A; Masas M; Balmaña J; Diez O
Gynecol Oncol; 2013 Nov; 131(2):460-3. PubMed ID: 23911796
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer.
Ihnen M; zu Eulenburg C; Kolarova T; Qi JW; Manivong K; Chalukya M; Dering J; Anderson L; Ginther C; Meuter A; Winterhoff B; Jones S; Velculescu VE; Venkatesan N; Rong HM; Dandekar S; Udar N; Jänicke F; Los G; Slamon DJ; Konecny GE
Mol Cancer Ther; 2013 Jun; 12(6):1002-15. PubMed ID: 23729402
[TBL] [Abstract][Full Text] [Related]
18. 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.
Aka JA; Zerradi M; Houle F; Huot J; Lin SX
Breast Cancer Res; 2012 Jun; 14(3):R92. PubMed ID: 22691413
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression in rainbow trout (Oncorhynchus mykiss) liver and ovary after exposure to zearalenone.
Woźny M; Brzuzan P; Wolińska L; Góra M; Łuczyński MK
Comp Biochem Physiol C Toxicol Pharmacol; 2012 Nov; 156(3-4):221-8. PubMed ID: 22683937
[TBL] [Abstract][Full Text] [Related]
20. Requirement of mouse BCCIP for neural development and progenitor proliferation.
Huang YY; Lu H; Liu S; Droz-Rosario R; Shen Z
PLoS One; 2012; 7(1):e30638. PubMed ID: 22292003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
